Plain-English translation of NCT07571109 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a new medication given as a weekly injection under the skin, to see if it can help people with excess body weight and obstructive sleep apnea (a condition where breathing stops and starts during sleep) lose weight and improve their sleep. The study will compare this medication to a placebo (a dummy injection with no active medicine) to see which works better. Everyone in the study will also be asked to follow a reduced-calorie diet and exercise more.
Obstructive sleep apnea is a serious condition that affects millions of people, and while positive airway pressure machines help, many people still struggle with excess weight and ongoing sleep problems. Researchers want to know if this medication can offer additional benefit beyond standard treatments and lifestyle changes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the new medication or a placebo as a weekly injection under your skin for several months, along with guidance on diet and exercise. You will visit the clinic regularly so researchers can check how well the treatment is working, measure your weight, monitor your sleep apnea, and watch for any side effects. The study involves 300 people total, and whether you get the active medication or placebo is decided randomly by chance.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States